Drug recognition expert evaluations made using limited data

Author： Smith J.A.   Hayes C.E.   Yolton R.L.   Rutledge D.A.   Citek K.  

Publisher： Elsevier

ISSN： 0379-0738

Source： Forensic Science International, Vol.130, Iss.2, 2002-12, pp. : 167-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using EHRs to design drug repositioning trials: A devolved approach to data protection

By Stauch Marc   Forgó Nikolaus   Krügel Tina  

International Review of Law, Computers & Technology, Vol. 28, Iss. 2, 2014-05 ,pp. : 237-248

Routledge Ltd

Access to resources Recommend Favorite

A Missed Opportunity: The Amazon Case That Almost Made Data Subjects Into Consumers

By Zanfir Fortuna Gabriela  

European Data Protection Law Review (EDPL), Vol. 2, Iss. 4, 2016-12 ,pp. : 585-589

Lexxion Verlagsgesellschaft mbH

Access to resources Recommend Favorite

Drug and chemical blood-level data 2001

By Winek C.L.   Wahba W.W.   Winek C.L.   Balzer T.W.  

Forensic Science International, Vol. 122, Iss. 2, 2001-11 ,pp. : 107-123

Elsevier

Access to resources Recommend Favorite

Oracle America Inc (Formerly Sun Microsystems Inc) v M-Tech Data Limited

By Sinclair Andrew  

European Law Reports, Vol. 16, Iss. 6, 2012-11 ,pp. : 727-746

Hart Publishing

Access to resources Recommend Favorite

Compensation: The EAT holds that unfair dismissal compensation is limited to economic loss only. Comments in Johnson v Unisys extending compensation to non-economic losses were made obiter, and did not change the law as. (p.4)

By  

Industrial Relations Law Bulletin, Vol. 719, Iss. 1, 2003-08 ,pp. : 4-7

Industrial Relations Services

Access to resources Recommend Favorite